Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Total Non-Current Liabilities: 2020

  • Cogent Biosciences' Total Non-Current Liabilities was N/A to $10.7 million in Q4 2020 from the same period last year, while for Dec 2020 it was $10.7 million, marking a year-over-year change of. This contributed to the annual value of $10.7 million for FY2020, which is N/A change from last year.
  • As of Q4 2020, Cogent Biosciences' Total Non-Current Liabilities stood at $10.7 million.
  • Cogent Biosciences' Total Non-Current Liabilities' 5-year high stood at $10.7 million during Q4 2020, with a 5-year trough of $10.7 million in Q4 2020.
  • Moreover, its 1-year median value for Total Non-Current Liabilities was $10.7 million (2020), whereas its average is $10.7 million.